期刊文献+

痘苗病毒滴度测定用国家标准品的制备 被引量:4

Preparation of national standard for determination of vaccinia virus titer
原文传递
导出
摘要 目的制备病毒载体疫苗滴度测定用国家标准品。方法以鸡胚成纤维细胞制备痘苗病毒,经密度梯度超速离心纯化后,加入天花疫苗保护剂,分装冻存,分发至我国4个不同实验室,按照统一的结晶紫染色蚀斑法实验方案进行协作标定,每次实验稀释后取2个稀释度,每个稀释度设5个平行孔,计算各实验室检测结果的几何均数,对标准品中痘苗病毒滴度进行赋值。检测病毒标准品于不同温度下保存不同时间的稳定性,并对病毒标准品的各项质量指标进行检定。结果 4个实验室共测定44次,4个实验室间的检测结果差异无统计学意义(P>0.05),各实验室检测结果的几何平均数为3.05×106PFU/ml,95%CI为2.00×106~4.65×106PFU/ml,标准差为0.09,总变异系数1.41%。制备的痘苗病毒标准品于4℃可稳定放置10 d,37℃放置稳定性较差。制备的痘苗病毒标准品装量检查合格(1 ml/支);pH值为6.9;无菌试验合格;分装重量精密性为0.95%。结论制备的痘苗病毒标准品可作为痘病毒载体疫苗滴度测定用标准品。 Objective To prepare the national standard for determination of titers of virus vector-based vaccines.Methods Vaccinia virus was prepared with chick embryo fibroblasts(CEFs),purified by density gradient ultracentrifuge,added with preservative for smallpox vaccine,then filled and stored in frozen,and distributed to four laboratories for cooperative calibration by plaque assay with crystal violet staining.The samples were diluted serially,and two dilutions were used for each test.Five parallel tests were performed on each dilution.The geometric mean of determination results in various laboratories was calculated,based on which the vaccinia virus titer in standard was defined.The virus standard after storage at various temperatures for various time durations were evaluated for stability,and subjected to overall control tests.Results A total of 44 tests were performed in four laboratories,and the results,with a geometric mean of 3.05 × 10^6 PFU / ml,a 95% CI of 2.00 × 10^6 ~ 4.65 × 10^6 PFU / ml,a standard deviation of 0.09 and a total CV value of 1.41%,showed no significant difference(P〉0.05).The prepared vaccinia virus standard was stable after storage at 4℃ for 10 d,while was less stable at 37℃,and was qualified in filling quantity(1 ml per container) and sterility test,of which the pH value was 6.9 and the precision for filling was 0.95% based on weight.Conclusion The prepared vaccinia virus standard may be used for determination of titers of vaccinia virus vector-based vaccines.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第9期1099-1101,1105,共4页 Chinese Journal of Biologicals
基金 十一五"国家传染病科技重大专项(2009ZX10004-801)
关键词 痘苗病毒 蚀斑滴定 标准品 Recombinant vaccinia virus Plaque assay Standard
  • 相关文献

参考文献7

二级参考文献46

  • 1Merchlinsky M, Moss B. Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation:recombination-independent selectable cloning vectors[J]. Virology, 1992, 190 (1):522-526.
  • 2Mackett M, Smith G L, Moss B. Vaceinia virus: a seleetable eukaryotic cloning and expression vector[J]. Proc Natl Acad Sci USA, 1982,79:7415-7419.
  • 3Brochier B, Aubert M F, Pastoret P P, et al. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and NorthAmeriea[J]. RevSciTech, 1996, 15 (3):947-1970.
  • 4James H S,Ellen G S. Viruses and human disease[M].北京:科学出版社,2006:223-227.
  • 5Mark R, Buller L, Gregory J P. Poxvirus pathogenesis [J]. Microbiol Rev, 1991, 55(1) :80-122.
  • 6Steven S B. Vaccinia virus transcription [J]. J Gen Virol, 2003,84 : 2293-2303.
  • 7Christina J K, Janiee C, Matthew R ,et al. Use of reeombiant poxviruses to stimulate anti-melanoma T Cell reaetivity[J]. Annu Surg Oncol,1998,5(1) : 64-76.
  • 8Merehlinsky M, Eckert D, Smith E. Construction and characterization of vaccinia direct ligation vectors[J]. Virology,1997,238:444-451.
  • 9Carroll M W,Moss B. Poxviruses as expression vectors[J]. Curr Opin Biotech, 1997, (8) : 573-577.
  • 10Hammond J M,Oke P G, Coupar B E H. A synthetic vaccinia virus promoter with enhanced early and late activity[J]. J VirolMethods, 1997, 66: 135-138.

共引文献24

同被引文献35

  • 1徐敬龙,金扩世,夏志平,贾雷立,郭建顺,金明兰,金宁一.重组鸡痘病毒vFV282疫苗株理化特性测定[J].动物医学进展,2005,26(3):84-85. 被引量:5
  • 2王文玲,黄保英,邓瑶,王秀平,谭文杰,阮力.甲3型流感病毒M2基因在痘苗病毒天坛株中的表达[J].病毒学报,2007,23(5):377-383. 被引量:10
  • 3金奇,陈南海,姚二梅,黄静,侯云德.痘苗病毒天坛株基因组旁侧区结构及开放读码框架的分析[J].病毒学报,1997,13(1):1-5. 被引量:8
  • 4Paran N, Lustig S, Zvi A, et al. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response[J]. Virol J, 2013, 299: 1-13.
  • 5Fan J, Chen X, Huang W, et al. Construction of non-replicating recombinant vaccinia virus expressing HPV16 Ll , L2E7 proteins [J]. Chi-Ger J Clin Oncol,2009, 8(5): 247-50.
  • 6Gerlic M, Faustin B, Postigo A, et al. Vaccinia virus FIL protein promotes virulence by inhibiting inflammasome activation[J]. PNAS, 2013, 110(19): 7808-13.
  • 7Breiman A. Carpentier DC. Ewles HA. et al. Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein[J]. J Gen Virol , 2013, 94:720-5.
  • 8Ferguson BJ, Benfield CHO. Ren H. et al. Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence[J]. J Gen Virol , 2013, 94: 2070-81.
  • 9Zhang Q, Tian M, Feng y, et al. Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan , the Chinese smallpox vaccine strain[J]. Plos One, 20 is, 8 (4): 1 -l3.
  • 10Gabriel P, Babiarova K, Zurkova K. et al. Chemokine binding protein vCCI attenuates vaccinia virus without affecting the cellular response elicited by immunization with a recombinant vaccinia vector carrying the HPV16 E7 gene[J]. Viral Immunol , 2012, 25 (5): 411-22.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部